ISLAMABAD: Pakistan’s Armed Forces Bone Marrow Transplant Center carried out its first-ever successful chimeric antigen receptor (CAR)-T cell therapy, state broadcaster Radio Pakistan reported this week, marking a major breakthrough in cancer treatment in the country.
CAR-T cell therapy is a cancer treatment that takes cells from the body and genetically changes them so they can fight cancer, according to US-based medical center Mayo Clinic. This therapy is most often used to treat cancers that affect blood cells, such as certain types of leukemia, lymphoma and multiple myeloma.
Radio Pakistan reported that the Armed Forces Bone Marrow Transplant Center carried out the procedure after years of research and innovation by specialists from the Army Medical Corps.
“A 21-year-old patient has made a full recovery following the treatment, while the patient and family demonstrated exemplary resilience throughout the process,” Radio Pakistan reported on Saturday.
With the successful treatment, Pakistan has joined the ranks of countries capable of offering cutting-edge CAR T-cell therapy, Radio Pakistan said, strengthening its standing in advanced cancer care.
“The achievement highlights the country’s growing medical expertise and its ability to deliver one of the world’s most sophisticated therapies for complex diseases,” it added.
